Cellectis (CLLS) Operating Leases (2018 - 2026)
Cellectis (CLLS) posted quarterly Operating Leases of $25.9 million for Q1 2026, down 21.7% year-over-year from $33.1 million in Q1 2025, and down 6.41% quarter-over-quarter from $27.7 million in Q4 2025.
Analysis
Cellectis (CLLS) Operating Leases (2018 - 2026) Analysis & Trends
Cellectis' Operating Leases history runs 9 years deep, the most recent figure standing at $25.9 million for Q1 2026.
- In Q1 2026, Operating Leases fell 21.7% year-over-year to $25.9 million; the TTM figure through Mar 2026 stood at $25.9 million (down 21.7% YoY), while the FY2025 annual figure was $27.7 million, down 19.04% from the prior year.
- Operating Leases for Q1 2026 stood at $25.9 million, down from $27.7 million in the prior quarter.
- The five-year high for Operating Leases was $69.7 million in Q1 2022, with the low at $25.9 million in Q1 2026.
- The 5-year median for Operating Leases is $40.6 million (2024), against an average of $42.9 million.
- The sharpest annual moves came in 2022 and 2023: Operating Leases fell 4.99% in 2022, then sank 31.1% in 2023.
- Cellectis' Operating Leases stood at $49.4 million in 2022, then dropped by 12.99% to $42.9 million in 2023, then decreased by 20.26% to $34.2 million in 2024, then decreased by 19.04% to $27.7 million in 2025, then fell by 6.41% to $25.9 million in 2026.
- Business Quant data shows CLLS's Operating Leases at $25.9 million in Q1 2026, $27.7 million in Q4 2025, and $29.3 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Cellectis | 321.90 Mn | 155.05 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 23.82 Mn |
| Mar 31, 2026 | 25.95 Mn |
| Dec 31, 2025 | 27.73 Mn |
| Sep 30, 2025 | 29.25 Mn |
| Jun 30, 2025 | 32.26 Mn |
| Mar 31, 2025 | 33.14 Mn |
| Dec 31, 2024 | 34.25 Mn |
| Sep 30, 2024 | 36.68 Mn |
| Jun 30, 2024 | 38.36 Mn |
| Mar 31, 2024 | 40.59 Mn |
| Dec 31, 2023 | 42.95 Mn |
| Sep 30, 2023 | 43.82 Mn |
| Jun 30, 2023 | 46.16 Mn |
| Mar 31, 2023 | 48.29 Mn |
| Dec 31, 2022 | 49.36 Mn |
| Sep 30, 2022 | 63.59 Mn |
| Jun 30, 2022 | 74.68 Mn |
| Mar 31, 2022 | 69.74 Mn |
| Dec 31, 2021 | 71.53 Mn |
| Sep 30, 2021 | 73.73 Mn |